|
| |
Helix BioPharma Corp.Helix BioPharma Corp. is a biopharmaceutical company focused on the development and commercialization of innovative cancer therapeutics. Helix's business model is to commercialize the new products that result from our development efforts by establishing strategic licensing arrangements with market leaders in the appropriate therapeutic fields.
| Contact Details: |
| 305 Industrial Parkway South, Unit 3 |
| Aurora |
| Ontario |
| L4G 6X7 |
| Canada |
| Tel: | (905) 841-2300 |
| Fax: | (905) 841-2244 |
| Email: | helix@helixbiopharma.com |
| WWW: | www.helixbiopharma.com/
|
|
Loading...
|
Press Releases on Helix BioPharma Corp.:
|
 |
| Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th |
6th November, 2009 |
Helix BioPharma Corp. |
AURORA, Ontario, Nov. 6 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / Pink Sheets: HXBPF) today announced that John Docherty, president and chief operating officer, will
|
| Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts |
5th November, 2009 |
Helix BioPharma Corp. |
AURORA, Ontario, Nov. 5 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced today that its Phase II trial of Topical Interferon Alpha-2b for the
|
| Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA |
6th October, 2009 |
|
AURORA, Ontario, October 6 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: HBP / OTCQX: HXBPF) today announced
progress updates for its ongoing Topical Interferon Alpha-2b and L-DOS47
product
|
| Helix BioPharma Announces CDN$13.5 Million Private Placement |
4th September, 2009 |
|
AURORA, Ontario, September 4 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: "HXBPF") today announced
that it has accepted subscriptions for the purchase, by way of
|
| Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF |
23rd June, 2009 |
Helix BioPharma Corp. |
AURORA, Ontario, June 23 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: HBP; OTCQX: HXBPF) announced today that it has commenced trading in the U.S. on the OTCQX International Market under
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 253 times since April 2007, the link to the organisation's website has been followed 49 times Search for more companies in Aurora Search for more companies in Ontario This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Helix BioPharma Corp. |
